Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Oncology & Cancer

Gene discovery may explain female melanoma survival advantage

Centenary Institute scientists have discovered that genes on the X chromosome may be key to the improved survival rates of females with melanoma–as compared to their male counterparts. The findings could ultimately lead ...

Oncology & Cancer

Internal differences: A new method for seeing into cells

Invading cells' private space—prying into their internal functions, decisions and communications—could be a powerful tool that may help researchers develop new immunotherapy treatment for cancer. As reported today in ...

Diseases, Conditions, Syndromes

Study reveals immune-system paralysis in severe COVID-19 cases

A Stanford study shows that in severely ill COVID-19 patients, "first-responder" immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.

Oncology & Cancer

Immunotherapy-resistant cancers eliminated in mouse study

Immunotherapy has revolutionized cancer treatment by stimulating the patient's own immune system to attack cancer cells, yielding remarkably quick and complete remission in some cases. But such drugs work for less than a ...

page 1 from 2